(1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester
![BK792V | 1256387-74-2 | (1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester](https://qncdn.chemcd.cn/alchemypharm/AP10072.png "BK792V | 1256387-74-2 | (1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester")
Catalog No.: BK792V
CAS.RN：1256387-74-2
Molecular Formula: C18H22BrN3O2
Molecular Weight: 392.29 g/mol
Purity: NLT 98%
Intermediates of Ledipasvir
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA6LD4 | Ledipasvir API | 1256388-51-8 |
| BK321F | (6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester | 1441670-89-8 |
| BK8S04 | 1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone | 1378387-81-5 |
| BK6F88 | (1R,3S,4S)-2-(tert-butoxycarbonyl)-2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid | 291775-59-2 |
| BK792V | (1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester | 1256387-74-2 |
| BK74U6 | (S)-5-BOC-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID | 1129634-44-1 |
| BK1YZ9 | (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester | 1256387-87-7 |
| BK1L75 | N-(Methoxycarbonyl)-L-valine | 74761-42-5 |
| BK8M1H | (6S)-5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid 5-(1,1-dimethylethyl) ester potassium salt (1:1) | 1441673-92-2 |
| BK44FM | Ledipasvir (acetone) | 1441674-54-9 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
